Seek Returns

AVTR vs. ELAN: Avantor vs. Elanco Animal Health Stock Comparison

How do Avantor (AVTR) and Elanco Animal Health (ELAN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Avantor (AVTR) and Elanco Animal Health (ELAN) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but AVTR is classified in Life Sciences Tools & Services while ELAN is classified in Pharmaceuticals.

Company profile comparison for Avantor (AVTR) and Elanco Animal Health (ELAN)
Profile ItemAVTRELAN
NameAvantor, Inc.Elanco Animal Health Incorporated
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesPharmaceuticals
GICS Sub-IndustryLife Sciences Tools & ServicesPharmaceuticals
Market Capitalization10.48 billion USD12.86 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateMay 17, 2019September 20, 2018
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

AVTR
ELAN
GSPC
Loading price history…
Avantor (AVTR) vs. Elanco Animal Health (ELAN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Avantor (AVTR) and Elanco Animal Health (ELAN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Avantor (AVTR) and Elanco Animal Health (ELAN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Avantor (AVTR) and Elanco Animal Health (ELAN)
MetricAVTRELAN
Total Return (1Y)36.41%24.03%
Total Return (3Y, Annualized)-5.02%37.47%
Total Return (5Y, Annualized)-16.62%-4.24%

Risk Profile

Drawdown History

AVTR
ELAN
GSPC
Loading price history…
Avantor (AVTR) vs. Elanco Animal Health (ELAN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Avantor (AVTR) and Elanco Animal Health (ELAN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Avantor (AVTR) and Elanco Animal Health (ELAN)
MetricAVTRELAN
Volatility (1Y, Annualized)43.39%43.57%
Beta (5Y)0.941.65
Max Drawdown (5Y)-82.42%-75.59%
Avg. Volume (3M)8.56M5.65M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
AVTR and ELAN are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Avantor (AVTR) and Elanco Animal Health (ELAN)
MetricAVTRELAN
Sharpe Ratio (1Y)0.740.45
Sortino Ratio (1Y)1.170.66

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Avantor (AVTR) earns 5.91% on shareholders’ equity, ranked against its industry; Elanco Animal Health (ELAN) has no ROE this period.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.91%

Max
109.18%
Q3
6.23%
AVTR
5.91%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ELAN
--
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): ELAN does not report ROE, so it has no value marker; AVTR is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Elanco Animal Health (ELAN) reports a negative net margin of -2.86%, usually indicating a net loss over the period. Meanwhile Avantor (AVTR) reports 5.08%, ranking against industry peers normally.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.08%

Max
18.05%
AVTR
5.08%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-2.86%

Max
18.05%
Q3
4.78%
Median
0.00%
ELAN
-2.86%
Q1
-4.14%
Min
-17.05%
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Both Avantor (AVTR) at 8.19% and Elanco Animal Health (ELAN) at 6.64% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.19%

Max
83.12%
Q3
14.77%
AVTR
8.19%
Median
0.00%
Q1
-78.82%
Min
-207.40%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.64%

Max
83.12%
Q3
14.77%
ELAN
6.64%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Avantor (AVTR) and Elanco Animal Health (ELAN)
MetricAVTRELAN
ROE (TTM)5.91%--
ROA (TTM)2.83%--
Net Margin (TTM)5.08%-2.86%
Operating Margin (TTM)8.19%6.64%
Gross Margin (TTM)31.59%56.18%

Growth

Revenue Growth

Elanco Animal Health (ELAN) at 6.22% is around its peer norm for revenue growth, while Avantor (AVTR) at -3.41% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both Avantor (AVTR) at -175.00% and Elanco Animal Health (ELAN) at -169.12% post bottom-quartile EPS growth versus peers, pointing to weaker earnings momentum than typical rivals.

Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Avantor (AVTR) and Elanco Animal Health (ELAN)
MetricAVTRELAN
Revenue Growth (YoY)-3.41%6.22%
Revenue Growth (3Y CAGR)-4.46%2.25%
EPS Growth (YoY)-175.00%-169.12%
EPS Growth (3Y CAGR)----

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: Avantor (AVTR) shows current ratio of 1.89 against its industry benchmark, while Elanco Animal Health (ELAN) has no reading this period.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.89

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
AVTR
1.89
Min
0.10

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
Min
0.10
ELAN
--
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): ELAN does not report current ratio, so it has no value marker; AVTR is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

Both Avantor (AVTR) at 0.63 and Elanco Animal Health (ELAN) at 0.64 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.63

Max
1.42
Q3
0.65
AVTR
0.63
Median
0.15
Q1
0.02
Min
0.00

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.64

Max
1.42
Q3
0.65
ELAN
0.64
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Avantor (AVTR) and Elanco Animal Health (ELAN)
MetricAVTRELAN
Current Ratio (MRQ)1.89--
Debt / Equity (MRQ)0.630.64
Net Debt / EBITDA3.403.49

Dividends

Dividend Yield (TTM)

Neither Avantor (AVTR) nor Elanco Animal Health (ELAN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

AVTR
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Avantor (AVTR) nor Elanco Animal Health (ELAN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

AVTR
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Avantor (AVTR) and Elanco Animal Health (ELAN)
MetricAVTRELAN
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: Avantor (AVTR) trades at 30.94 times trailing earnings, ranked against its peers, while Elanco Animal Health (ELAN) has no P/E ratio this period.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

30.94

Max
85.34
Q3
43.46
AVTR
30.94
Median
26.69
Q1
13.30
Min
0.07

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
ELAN
--
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): ELAN does not report P/E ratio, so it has no value marker; AVTR is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

Both Avantor (AVTR) at 1.58 and Elanco Animal Health (ELAN) at 2.50 fetch a relatively low price per dollar of sales, landing in the cheaper P/S ratio quartile of their industries.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.58

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
AVTR
1.58
Min
0.01

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.50

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
ELAN
2.50
Min
0.01
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

On P/B ratio, both Avantor (AVTR) at 1.80 and Elanco Animal Health (ELAN) at 1.95 are valued close to their industries’ norm against book — neither stands out from peers.

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.80

Max
13.53
Q3
6.54
Median
3.25
AVTR
1.80
Q1
1.69
Min
-5.59

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.95

Max
13.53
Q3
6.54
Median
3.25
ELAN
1.95
Q1
1.69
Min
-5.59
Loading chart…
Avantor (AVTR) vs. Elanco Animal Health (ELAN): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Avantor (AVTR) and Elanco Animal Health (ELAN)
MetricAVTRELAN
P/E Ratio (TTM)30.94--
P/S Ratio (TTM)1.582.50
P/B Ratio (MRQ)1.801.95
Free Cash Flow Yield (TTM)4.21%--